Geron Corporation (GERN) P/E Ratio History
Historical price-to-earnings valuation from 2016 to 2016
Loading P/E history...
GERN Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Geron Corporation (GERN) trades at a price-to-earnings ratio of -11.2x, with a stock price of $1.46 and trailing twelve-month earnings per share of $-0.10.
The current P/E is 101% below its 5-year average of 1061.9x. Over the past five years, GERN's P/E has ranged from a low of 406.1x to a high of 1717.6x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, GERN trades at a 150% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, GERN trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our GERN DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
GERN P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $5B | 8.3Lowest | -Best | +264% | |
| $7B | 15.5 | -Best | +1747%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
GERN Historical P/E Data (2016–2016)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2016 Q2 | $2.68 | $0.01 | 406.1x | -62% | |
| FY2016 Q1 | $2.92 | $0.00 | 1717.6x | +62% |
Average P/E for displayed period: 1061.9x
See GERN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GERN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GERN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGERN — Frequently Asked Questions
Quick answers to the most common questions about buying GERN stock.
Is GERN stock overvalued or undervalued?
GERN trades at -11.2x P/E, below its 5-year average of 1061.9x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does GERN's valuation compare to peers?
Geron Corporation P/E of -11.2x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is GERN's PEG ratio?
GERN PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2016-2016.